Trial Review

Did you know?

The ANZCTR now automatically displays published trial results and simplifies the addition of trial documents such as unpublished protocols and statistical analysis plans.

These enhancements will offer a more comprehensive view of trials, regardless of whether their results are positive, negative, or inconclusive.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT03701334




Registration number
NCT03701334
Ethics application status
Date submitted
21/09/2018
Date registered
10/10/2018
Date last updated
10/10/2024

Titles & IDs
Public title
A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer
Scientific title
A Phase III Multi-center, Randomized, Open-label Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as an Adjuvant Treatment in Patients With Hormone Receptor-positive, HER2-negative Early Breast Cancer (New Adjuvant TriAl With Ribociclib [LEE011]: NATALEE)
Secondary ID [1] 0 0
2018-002998-21
Secondary ID [2] 0 0
CLEE011O12301C
Universal Trial Number (UTN)
Trial acronym
NATALEE
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Early Breast Cancer 0 0
Condition category
Condition code
Cancer 0 0 0 0
Breast

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Drugs - Ribociclib
Other interventions - Endocrine Therapy

Experimental: Ribociclib + Endocrine Therapy - Participants will receive ribociclib 400 mg once daily on days 1-21 of a 28-day cycle and endocrine therapy once daily continuously

Active comparator: Endocrine Therapy - Participants will receive endocrine therapy only once daily continuously


Treatment: Drugs: Ribociclib
Ribociclib orally taken at 400 mg on days 1 to 21 of a 28-day cycle

Other interventions: Endocrine Therapy
ET will be administered according to the local clinical guidelines and current local prescribing information
Intervention code [1] 0 0
Treatment: Drugs
Intervention code [2] 0 0
Other interventions
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Invasive Disease-Free Survival (iDFS)
Timepoint [1] 0 0
Up to approximately 91 months
Secondary outcome [1] 0 0
Recurrence-free survival (RFS)
Timepoint [1] 0 0
Up to approximately 91 months
Secondary outcome [2] 0 0
Distant disease-free survival (DDFS)
Timepoint [2] 0 0
Up to approximately 91 months
Secondary outcome [3] 0 0
Overall Survival (OS)
Timepoint [3] 0 0
Up to approximately 91 months
Secondary outcome [4] 0 0
Change from baseline in the global health status Quality of life scale score as assessed by EORTC QLQ-C30
Timepoint [4] 0 0
Up to approximately 91 months
Secondary outcome [5] 0 0
Change from baseline in the physical functioning sub-scale score as assessed by EORTC QLQ-C30
Timepoint [5] 0 0
Up to approximately 91 months
Secondary outcome [6] 0 0
PK parameters: Ctrough and other applicable parameters for ribociclib
Timepoint [6] 0 0
Cycle 1 Day 15

Eligibility
Key inclusion criteria
* Patient is = 18 years-old at the time of PICF signature
* Patient is female with known menopausal status at the time of randomization or initiation of adjuvant ET (whichever occurs earlier), or male.
* Patient with histologically confirmed unilateral primary invasive adenocarcinoma of the breast with a date of initial cytologic or histologic diagnosis within 18 months prior to randomization.
* Patient has breast cancer that is positive for ER and/or PgR
* Patient has HER2-negative breast cancer
* Patient has available archival tumor tissue from the surgical specimen
* Patient after surgical resection where tumor was removed completely, with the final surgical specimen microscopic margins free from tumor, and belongs to one of the following categories: anatomic stage group II or III
* If indicated, patient has completed adjuvant and/or neoadjuvant chemotherapy according to the institutional guidelines
* If indicated, patient has completed adjuvant radiotherapy according to the institutional guidelines
* Patient has an Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1.
* Patient has no contraindication for the adjuvant ET in the trial and is planned to be treated with ET for 5 years
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* Patient has received any CDK4/6 inhibitor
* Patient has received prior treatment with tamoxifen, raloxifene or AIs for reduction in risk ("chemoprevention") of breast cancer and/or treatment for osteoporosis within the last 2 years prior to randomization. Patient is concurrently using hormone replacement therapy.
* Patient has received prior treatment with anthracyclines at cumulative doses of 450 mg/m² or more for doxorubicin, or 900 mg/m² or more for epirubicin.
* Patient with a known hypersensitivity to any of the excipients of ribociclib and/or ET
* Patient with distant metastases of breast cancer beyond regional lymph nodes (stage IV according to AJCC 8th edition) and/or evidence of recurrence after curative surgery.
* Patient is concurrently using other anti-neoplastic therapy with the exception of adjuvant ET
* Patient has had major surgery, chemotherapy or radiotherapy within 14 days prior to randomization
* Patient has not recovered from clinical and laboratory acute toxicities related to prior anti-cancer therapies
* Patient has a concurrent invasive malignancy or a prior invasive malignancy whose treatment was completed within 2 years before randomization
* Patient has known HIV infection, Hepatitis B or C infection
* Clinically significant, uncontrolled heart disease and/or cardiac repolarization abnormality
* Patient is currently receiving any of the following substances within 7 days before randomization - Concomitant medications, herbal supplements, and/or fruits that are known as strong inhibitors or inducers of CYP3A4/5 or Medications that have a narrow therapeutic window and are predominantly metabolized through CYP3A4/5
* is currently receiving or has received systemic corticosteroids = 2 weeks prior to starting trial treatment
* Patient has impairment of GI function or GI disease that may significantly alter the absorption of the oral trial treatments
* Patient has any other concurrent severe and/or uncontrolled medical condition that would, in the Investigator's judgment, cause unacceptable safety risks, contraindicate patient participation in the clinical trial or compromise compliance with the protocol
* Participation in other studies involving investigational drug(s) within 30 days prior to randomization or within 5 half-lives of the investigational drug(s) (whichever is longer), or participation in any other type of medical research judged not to be scientifically or medically compatible with this trial.
* Pregnant or breast-feeding (lactating) women or women who plan to become pregnant or breast-feed during the trial

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Phase 3
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Active, not recruiting
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
7/12/2018
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
29/05/2026
Actual
Sample size
Target
Accrual to date
Final
5101
Recruitment in Australia
Recruitment state(s)
NSW,QLD,SA,VIC,WA
Recruitment hospital [1] 0 0
Novartis Investigative Site - Campbelltown
Recruitment hospital [2] 0 0
Novartis Investigative Site - Coffs Harbour
Recruitment hospital [3] 0 0
Novartis Investigative Site - Darlinghurst
Recruitment hospital [4] 0 0
Novartis Investigative Site - Kingswood
Recruitment hospital [5] 0 0
Novartis Investigative Site - Kogarah
Recruitment hospital [6] 0 0
Novartis Investigative Site - North Ryde
Recruitment hospital [7] 0 0
Novartis Investigative Site - St Leonards
Recruitment hospital [8] 0 0
Novartis Investigative Site - Wahroonga
Recruitment hospital [9] 0 0
Novartis Investigative Site - Westmead
Recruitment hospital [10] 0 0
Novartis Investigative Site - Auchenflower
Recruitment hospital [11] 0 0
Novartis Investigative Site - Birtinya
Recruitment hospital [12] 0 0
Novartis Investigative Site - Wooloongabba
Recruitment hospital [13] 0 0
Novartis Investigative Site - Bedford Park
Recruitment hospital [14] 0 0
Novartis Investigative Site - Bendigo
Recruitment hospital [15] 0 0
Novartis Investigative Site - East Melbourne
Recruitment hospital [16] 0 0
Novartis Investigative Site - Epping
Recruitment hospital [17] 0 0
Novartis Investigative Site - Fitzroy
Recruitment hospital [18] 0 0
Novartis Investigative Site - Franston
Recruitment hospital [19] 0 0
Novartis Investigative Site - Heidelberg
Recruitment hospital [20] 0 0
Novartis Investigative Site - Melbourne
Recruitment hospital [21] 0 0
Novartis Investigative Site - Shepparton
Recruitment hospital [22] 0 0
Novartis Investigative Site - Murdoch
Recruitment hospital [23] 0 0
Novartis Investigative Site - Nedlands
Recruitment hospital [24] 0 0
Novartis Investigative Site - Liverpool
Recruitment postcode(s) [1] 0 0
2560 - Campbelltown
Recruitment postcode(s) [2] 0 0
2450 - Coffs Harbour
Recruitment postcode(s) [3] 0 0
2010 - Darlinghurst
Recruitment postcode(s) [4] 0 0
2747 - Kingswood
Recruitment postcode(s) [5] 0 0
2217 - Kogarah
Recruitment postcode(s) [6] 0 0
2109 - North Ryde
Recruitment postcode(s) [7] 0 0
2065 - St Leonards
Recruitment postcode(s) [8] 0 0
2076 - Wahroonga
Recruitment postcode(s) [9] 0 0
2145 - Westmead
Recruitment postcode(s) [10] 0 0
4066 - Auchenflower
Recruitment postcode(s) [11] 0 0
4575 - Birtinya
Recruitment postcode(s) [12] 0 0
4102 - Wooloongabba
Recruitment postcode(s) [13] 0 0
5041 - Bedford Park
Recruitment postcode(s) [14] 0 0
3550 - Bendigo
Recruitment postcode(s) [15] 0 0
3002 - East Melbourne
Recruitment postcode(s) [16] 0 0
3076 - Epping
Recruitment postcode(s) [17] 0 0
3065 - Fitzroy
Recruitment postcode(s) [18] 0 0
3199 - Franston
Recruitment postcode(s) [19] 0 0
3084 - Heidelberg
Recruitment postcode(s) [20] 0 0
3000 - Melbourne
Recruitment postcode(s) [21] 0 0
3630 - Shepparton
Recruitment postcode(s) [22] 0 0
6150 - Murdoch
Recruitment postcode(s) [23] 0 0
6009 - Nedlands
Recruitment postcode(s) [24] 0 0
2170 - Liverpool
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
Alabama
Country [2] 0 0
United States of America
State/province [2] 0 0
Arizona
Country [3] 0 0
United States of America
State/province [3] 0 0
Arkansas
Country [4] 0 0
United States of America
State/province [4] 0 0
California
Country [5] 0 0
United States of America
State/province [5] 0 0
Colorado
Country [6] 0 0
United States of America
State/province [6] 0 0
Connecticut
Country [7] 0 0
United States of America
State/province [7] 0 0
Florida
Country [8] 0 0
United States of America
State/province [8] 0 0
Georgia
Country [9] 0 0
United States of America
State/province [9] 0 0
Illinois
Country [10] 0 0
United States of America
State/province [10] 0 0
Indiana
Country [11] 0 0
United States of America
State/province [11] 0 0
Kansas
Country [12] 0 0
United States of America
State/province [12] 0 0
Kentucky
Country [13] 0 0
United States of America
State/province [13] 0 0
Maryland
Country [14] 0 0
United States of America
State/province [14] 0 0
Massachusetts
Country [15] 0 0
United States of America
State/province [15] 0 0
Michigan
Country [16] 0 0
United States of America
State/province [16] 0 0
Minnesota
Country [17] 0 0
United States of America
State/province [17] 0 0
Missouri
Country [18] 0 0
United States of America
State/province [18] 0 0
Montana
Country [19] 0 0
United States of America
State/province [19] 0 0
Nebraska
Country [20] 0 0
United States of America
State/province [20] 0 0
Nevada
Country [21] 0 0
United States of America
State/province [21] 0 0
New Jersey
Country [22] 0 0
United States of America
State/province [22] 0 0
New York
Country [23] 0 0
United States of America
State/province [23] 0 0
North Carolina
Country [24] 0 0
United States of America
State/province [24] 0 0
Oregon
Country [25] 0 0
United States of America
State/province [25] 0 0
Pennsylvania
Country [26] 0 0
United States of America
State/province [26] 0 0
Tennessee
Country [27] 0 0
United States of America
State/province [27] 0 0
Texas
Country [28] 0 0
United States of America
State/province [28] 0 0
Utah
Country [29] 0 0
United States of America
State/province [29] 0 0
Virginia
Country [30] 0 0
United States of America
State/province [30] 0 0
Washington
Country [31] 0 0
United States of America
State/province [31] 0 0
Wisconsin
Country [32] 0 0
Argentina
State/province [32] 0 0
Santa Fe
Country [33] 0 0
Argentina
State/province [33] 0 0
Sante Fe
Country [34] 0 0
Argentina
State/province [34] 0 0
Tucuman
Country [35] 0 0
Argentina
State/province [35] 0 0
Viedma
Country [36] 0 0
Argentina
State/province [36] 0 0
Caba
Country [37] 0 0
Argentina
State/province [37] 0 0
Cordoba
Country [38] 0 0
Argentina
State/province [38] 0 0
Jujuy
Country [39] 0 0
Argentina
State/province [39] 0 0
La Rioja
Country [40] 0 0
Austria
State/province [40] 0 0
Tyrol
Country [41] 0 0
Austria
State/province [41] 0 0
Graz
Country [42] 0 0
Austria
State/province [42] 0 0
Linz
Country [43] 0 0
Austria
State/province [43] 0 0
Salzburg
Country [44] 0 0
Austria
State/province [44] 0 0
Wien
Country [45] 0 0
Belgium
State/province [45] 0 0
Bruxelles
Country [46] 0 0
Belgium
State/province [46] 0 0
Charleroi
Country [47] 0 0
Belgium
State/province [47] 0 0
Edegem
Country [48] 0 0
Belgium
State/province [48] 0 0
Hasselt
Country [49] 0 0
Belgium
State/province [49] 0 0
Jette
Country [50] 0 0
Belgium
State/province [50] 0 0
Leuven
Country [51] 0 0
Belgium
State/province [51] 0 0
Libramont
Country [52] 0 0
Belgium
State/province [52] 0 0
Liege
Country [53] 0 0
Belgium
State/province [53] 0 0
Namur
Country [54] 0 0
Belgium
State/province [54] 0 0
Wilrijk
Country [55] 0 0
Belgium
State/province [55] 0 0
Yvoir
Country [56] 0 0
Brazil
State/province [56] 0 0
PR
Country [57] 0 0
Brazil
State/province [57] 0 0
Rio Grande Do Sul
Country [58] 0 0
Brazil
State/province [58] 0 0
RS
Country [59] 0 0
Brazil
State/province [59] 0 0
Sao Paulo
Country [60] 0 0
Brazil
State/province [60] 0 0
SP
Country [61] 0 0
Brazil
State/province [61] 0 0
Caxias do Sul
Country [62] 0 0
Brazil
State/province [62] 0 0
Passo Fundo
Country [63] 0 0
Brazil
State/province [63] 0 0
Piracicaba
Country [64] 0 0
Brazil
State/province [64] 0 0
Recife
Country [65] 0 0
Brazil
State/province [65] 0 0
Rio De Janeiro
Country [66] 0 0
Brazil
State/province [66] 0 0
Salvador
Country [67] 0 0
Canada
State/province [67] 0 0
Alberta
Country [68] 0 0
Canada
State/province [68] 0 0
British Columbia
Country [69] 0 0
Canada
State/province [69] 0 0
Nova Scotia
Country [70] 0 0
Canada
State/province [70] 0 0
Ontario
Country [71] 0 0
Canada
State/province [71] 0 0
Quebec
Country [72] 0 0
China
State/province [72] 0 0
Guangdong
Country [73] 0 0
China
State/province [73] 0 0
Hebei
Country [74] 0 0
China
State/province [74] 0 0
Heilongjiang
Country [75] 0 0
China
State/province [75] 0 0
Henan
Country [76] 0 0
China
State/province [76] 0 0
Hubei
Country [77] 0 0
China
State/province [77] 0 0
Jiangsu
Country [78] 0 0
China
State/province [78] 0 0
Jilin
Country [79] 0 0
China
State/province [79] 0 0
Sichuan
Country [80] 0 0
China
State/province [80] 0 0
Zhejiang
Country [81] 0 0
China
State/province [81] 0 0
Beijing
Country [82] 0 0
China
State/province [82] 0 0
Chongqing
Country [83] 0 0
China
State/province [83] 0 0
Shanghai
Country [84] 0 0
China
State/province [84] 0 0
Tianjin
Country [85] 0 0
China
State/province [85] 0 0
Zhenjiang
Country [86] 0 0
France
State/province [86] 0 0
Alpes Maritimes
Country [87] 0 0
France
State/province [87] 0 0
Cote D Or
Country [88] 0 0
France
State/province [88] 0 0
Haute Vienne
Country [89] 0 0
France
State/province [89] 0 0
Hauts De Seine
Country [90] 0 0
France
State/province [90] 0 0
Ille Et Vilaine
Country [91] 0 0
France
State/province [91] 0 0
Isere
Country [92] 0 0
France
State/province [92] 0 0
Rhone
Country [93] 0 0
France
State/province [93] 0 0
Amiens
Country [94] 0 0
France
State/province [94] 0 0
Angers 02
Country [95] 0 0
France
State/province [95] 0 0
Argenteuil
Country [96] 0 0
France
State/province [96] 0 0
Avignon
Country [97] 0 0
France
State/province [97] 0 0
Besancon Cedex
Country [98] 0 0
France
State/province [98] 0 0
Bordeaux
Country [99] 0 0
France
State/province [99] 0 0
Bron Cedex
Country [100] 0 0
France
State/province [100] 0 0
Caen
Country [101] 0 0
France
State/province [101] 0 0
Le Mans
Country [102] 0 0
France
State/province [102] 0 0
Marseille
Country [103] 0 0
France
State/province [103] 0 0
Montpellier
Country [104] 0 0
France
State/province [104] 0 0
Nantes 2
Country [105] 0 0
France
State/province [105] 0 0
Paris 10
Country [106] 0 0
France
State/province [106] 0 0
Paris 13
Country [107] 0 0
France
State/province [107] 0 0
Paris
Country [108] 0 0
France
State/province [108] 0 0
Pierre Benite
Country [109] 0 0
France
State/province [109] 0 0
Rouen
Country [110] 0 0
France
State/province [110] 0 0
Saint Herblain
Country [111] 0 0
France
State/province [111] 0 0
Strasbourg
Country [112] 0 0
France
State/province [112] 0 0
Toulouse
Country [113] 0 0
France
State/province [113] 0 0
Vandoeuvre-les-Nancy
Country [114] 0 0
France
State/province [114] 0 0
Villejuif
Country [115] 0 0
Germany
State/province [115] 0 0
Baden Wuerttemberg
Country [116] 0 0
Germany
State/province [116] 0 0
Bavaria
Country [117] 0 0
Germany
State/province [117] 0 0
Lower Saxony
Country [118] 0 0
Germany
State/province [118] 0 0
Niedersachsen
Country [119] 0 0
Germany
State/province [119] 0 0
Nordrhein Westfalen
Country [120] 0 0
Germany
State/province [120] 0 0
North Rhine-Westphalia
Country [121] 0 0
Germany
State/province [121] 0 0
Augsburg
Country [122] 0 0
Germany
State/province [122] 0 0
Bad Liebenwerda
Country [123] 0 0
Germany
State/province [123] 0 0
Berlin
Country [124] 0 0
Germany
State/province [124] 0 0
Bonn
Country [125] 0 0
Germany
State/province [125] 0 0
Bottrop
Country [126] 0 0
Germany
State/province [126] 0 0
Cottbus
Country [127] 0 0
Germany
State/province [127] 0 0
Dresden
Country [128] 0 0
Germany
State/province [128] 0 0
Erlangen
Country [129] 0 0
Germany
State/province [129] 0 0
Essen
Country [130] 0 0
Germany
State/province [130] 0 0
Frankfurt
Country [131] 0 0
Germany
State/province [131] 0 0
Hamburg
Country [132] 0 0
Germany
State/province [132] 0 0
Kiel
Country [133] 0 0
Germany
State/province [133] 0 0
Mainz
Country [134] 0 0
Germany
State/province [134] 0 0
Mannheim
Country [135] 0 0
Germany
State/province [135] 0 0
Moenchengladbach
Country [136] 0 0
Germany
State/province [136] 0 0
Muenchen
Country [137] 0 0
Germany
State/province [137] 0 0
Muenster
Country [138] 0 0
Germany
State/province [138] 0 0
Munchen
Country [139] 0 0
Germany
State/province [139] 0 0
Regensburg
Country [140] 0 0
Germany
State/province [140] 0 0
Schweinfurt
Country [141] 0 0
Germany
State/province [141] 0 0
Tuebingen
Country [142] 0 0
Germany
State/province [142] 0 0
Ulm
Country [143] 0 0
Germany
State/province [143] 0 0
Wuerzburg
Country [144] 0 0
Hungary
State/province [144] 0 0
Zala
Country [145] 0 0
Hungary
State/province [145] 0 0
Budapest
Country [146] 0 0
Hungary
State/province [146] 0 0
Debrecen
Country [147] 0 0
Hungary
State/province [147] 0 0
Kecskemet
Country [148] 0 0
Hungary
State/province [148] 0 0
Pecs
Country [149] 0 0
Hungary
State/province [149] 0 0
Szeged
Country [150] 0 0
Hungary
State/province [150] 0 0
Szekszard
Country [151] 0 0
Hungary
State/province [151] 0 0
Szombathely
Country [152] 0 0
Hungary
State/province [152] 0 0
Tatabanya
Country [153] 0 0
Ireland
State/province [153] 0 0
Cork
Country [154] 0 0
Ireland
State/province [154] 0 0
County Limerick
Country [155] 0 0
Ireland
State/province [155] 0 0
Dublin 4
Country [156] 0 0
Ireland
State/province [156] 0 0
Dublin 7
Country [157] 0 0
Ireland
State/province [157] 0 0
Dublin
Country [158] 0 0
Ireland
State/province [158] 0 0
Waterford
Country [159] 0 0
Italy
State/province [159] 0 0
AN
Country [160] 0 0
Italy
State/province [160] 0 0
BG
Country [161] 0 0
Italy
State/province [161] 0 0
BO
Country [162] 0 0
Italy
State/province [162] 0 0
CT
Country [163] 0 0
Italy
State/province [163] 0 0
MI
Country [164] 0 0
Italy
State/province [164] 0 0
PA
Country [165] 0 0
Italy
State/province [165] 0 0
PN
Country [166] 0 0
Italy
State/province [166] 0 0
RM
Country [167] 0 0
Italy
State/province [167] 0 0
TO
Country [168] 0 0
Italy
State/province [168] 0 0
Napoli
Country [169] 0 0
Korea, Republic of
State/province [169] 0 0
Chungcheongbuk Do
Country [170] 0 0
Korea, Republic of
State/province [170] 0 0
Daegu
Country [171] 0 0
Korea, Republic of
State/province [171] 0 0
Gangwon-do
Country [172] 0 0
Korea, Republic of
State/province [172] 0 0
Gyeonggi Do
Country [173] 0 0
Korea, Republic of
State/province [173] 0 0
Korea
Country [174] 0 0
Korea, Republic of
State/province [174] 0 0
Seocho Gu
Country [175] 0 0
Korea, Republic of
State/province [175] 0 0
Incheon
Country [176] 0 0
Korea, Republic of
State/province [176] 0 0
Seongnam Si Gyeonggi Do
Country [177] 0 0
Korea, Republic of
State/province [177] 0 0
Seoul
Country [178] 0 0
Korea, Republic of
State/province [178] 0 0
Ulsan
Country [179] 0 0
Poland
State/province [179] 0 0
Ul Roentgena 5
Country [180] 0 0
Poland
State/province [180] 0 0
Bialystok
Country [181] 0 0
Poland
State/province [181] 0 0
Gdynia
Country [182] 0 0
Poland
State/province [182] 0 0
Gliwice
Country [183] 0 0
Poland
State/province [183] 0 0
Grudziadz
Country [184] 0 0
Poland
State/province [184] 0 0
Krakow
Country [185] 0 0
Poland
State/province [185] 0 0
Lodz
Country [186] 0 0
Poland
State/province [186] 0 0
Lublin
Country [187] 0 0
Poland
State/province [187] 0 0
Opole
Country [188] 0 0
Poland
State/province [188] 0 0
Ostroleka
Country [189] 0 0
Poland
State/province [189] 0 0
Otwock
Country [190] 0 0
Poland
State/province [190] 0 0
Wieliszew
Country [191] 0 0
Poland
State/province [191] 0 0
Wroclaw
Country [192] 0 0
Romania
State/province [192] 0 0
Dolj
Country [193] 0 0
Romania
State/province [193] 0 0
Bucuresti
Country [194] 0 0
Romania
State/province [194] 0 0
Cluj-Napoca
Country [195] 0 0
Romania
State/province [195] 0 0
Timisoara
Country [196] 0 0
Russian Federation
State/province [196] 0 0
Saint Petersburg
Country [197] 0 0
Russian Federation
State/province [197] 0 0
Chelyabinsk
Country [198] 0 0
Russian Federation
State/province [198] 0 0
Kazan
Country [199] 0 0
Russian Federation
State/province [199] 0 0
Kostroma
Country [200] 0 0
Russian Federation
State/province [200] 0 0
Krasnoyarsk
Country [201] 0 0
Russian Federation
State/province [201] 0 0
Moscow
Country [202] 0 0
Russian Federation
State/province [202] 0 0
Nizhniy Novgorod
Country [203] 0 0
Russian Federation
State/province [203] 0 0
Novosibirsk
Country [204] 0 0
Russian Federation
State/province [204] 0 0
Obninsk
Country [205] 0 0
Russian Federation
State/province [205] 0 0
Omsk
Country [206] 0 0
Russian Federation
State/province [206] 0 0
Orenburg
Country [207] 0 0
Russian Federation
State/province [207] 0 0
Rostov na Donu
Country [208] 0 0
Russian Federation
State/province [208] 0 0
Ryazan
Country [209] 0 0
Russian Federation
State/province [209] 0 0
St Petersburg
Country [210] 0 0
Russian Federation
State/province [210] 0 0
Tyumen
Country [211] 0 0
Russian Federation
State/province [211] 0 0
Ufa
Country [212] 0 0
Russian Federation
State/province [212] 0 0
Yaroslavl
Country [213] 0 0
Spain
State/province [213] 0 0
Alicante
Country [214] 0 0
Spain
State/province [214] 0 0
Andalucia
Country [215] 0 0
Spain
State/province [215] 0 0
Barcelona
Country [216] 0 0
Spain
State/province [216] 0 0
Castilla Y Leon
Country [217] 0 0
Spain
State/province [217] 0 0
Catalunya
Country [218] 0 0
Spain
State/province [218] 0 0
Comunidad Valenciana
Country [219] 0 0
Spain
State/province [219] 0 0
Extremadura
Country [220] 0 0
Spain
State/province [220] 0 0
Galicia
Country [221] 0 0
Spain
State/province [221] 0 0
Madrid
Country [222] 0 0
Spain
State/province [222] 0 0
Murcia
Country [223] 0 0
Spain
State/province [223] 0 0
Navarra
Country [224] 0 0
Spain
State/province [224] 0 0
Pais Vasco
Country [225] 0 0
Spain
State/province [225] 0 0
Pontevedra
Country [226] 0 0
Spain
State/province [226] 0 0
Santa Cruz De Tenerife
Country [227] 0 0
Spain
State/province [227] 0 0
Burgos
Country [228] 0 0
Spain
State/province [228] 0 0
Girona
Country [229] 0 0
Spain
State/province [229] 0 0
Granada
Country [230] 0 0
Spain
State/province [230] 0 0
Las Palmas de Gran Canaria
Country [231] 0 0
Spain
State/province [231] 0 0
Zaragoza
Country [232] 0 0
Taiwan
State/province [232] 0 0
Changhua
Country [233] 0 0
Taiwan
State/province [233] 0 0
Taichung
Country [234] 0 0
Taiwan
State/province [234] 0 0
Tainan
Country [235] 0 0
Taiwan
State/province [235] 0 0
Taipei
Country [236] 0 0
Taiwan
State/province [236] 0 0
Taoyuan
Country [237] 0 0
United Kingdom
State/province [237] 0 0
Cornwall
Country [238] 0 0
United Kingdom
State/province [238] 0 0
Surrey
Country [239] 0 0
United Kingdom
State/province [239] 0 0
Cardiff
Country [240] 0 0
United Kingdom
State/province [240] 0 0
London
Country [241] 0 0
United Kingdom
State/province [241] 0 0
Nottingham
Country [242] 0 0
United Kingdom
State/province [242] 0 0
Oxford
Country [243] 0 0
United Kingdom
State/province [243] 0 0
Preston
Country [244] 0 0
United Kingdom
State/province [244] 0 0
Stoke-on-Trent

Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Name
Novartis Pharmaceuticals
Address
Country
Other collaborator category [1] 0 0
Other
Name [1] 0 0
Translational Research in Oncology
Address [1] 0 0
Country [1] 0 0

Ethics approval
Ethics application status

Summary
Brief summary
A phase III multi-center, randomized, open-label trial to evaluate efficacy and safety of ribociclib with endocrine therapy as adjuvant treatment in patients with HR+/HER2- Early Breast Cancer (EBC)
Trial website
https://clinicaltrials.gov/study/NCT03701334
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Novartis Pharmaceuticals
Address 0 0
Novartis Pharmaceuticals
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries



Summary Results

For IPD and results data, please see https://clinicaltrials.gov/study/NCT03701334